ScienceHealth Ozempic and Other GLP-1 Drugs May Cut Cancer Risk New research suggests GLP-1 drugs like Ozempic can help prevent up to 10 different obesity-related cancers in people with type 2 diabetes. By Ed Cara Updated July 5, 2024 | Comments (0)
ScienceHealth Ozempic and Wegovy Linked to Rare Blindness Risk, Study Finds New research has found a potential link between semaglutide use and a rare eye condition called NAION, though more work is needed to prove causation. By Ed Cara Published July 3, 2024 | Comments (0)
ScienceHealth Next Gen Weight Loss Drugs Are Coming for Ozempic’s Throne Dozens of obesity and diabetes treatments are in the pipeline, some of which may help people lose even more weight than existing drugs like semaglutide. By Ed Cara Published June 25, 2024 | Comments (0)
ScienceHealth How to Avoid ‘Fauxzempic,’ According to WHO Experts The UN agency has received reports of medication falsified to look like the diabetes and weight loss drug Ozempic in at least 3 countries, including the U.S. By Ed Cara Published June 21, 2024 | Comments (0)
ScienceHealth Hey Teens, No Obesity Meds for You, Experts Say Experts with the U.S. Preventive Services Task Force say not enough data has been collected to know whether newer obesity medications for teens are safe. By Ed Cara Published June 18, 2024 | Comments (0)
ScienceHealth Pharma Exec Will Testify About Ozempic’s Absurd Price Tag After Pressure From Bernie Sanders Americans pay $969 a month for Ozempic, while Canadians pay just $155. By Matt Novak Published June 15, 2024 | Comments (0)
ScienceHealth The Truth About Ozempic and Muscle Loss Critics claim that drugs like semaglutide and other GLP-1s can dangerously sap away our muscle mass, but what does the current science actually tell us? By Ed Cara Published June 14, 2024 | Comments (0)
Science Spin of Supermassive Black Hole Measured at a Quarter the Speed of Light Plus: Marines test Mycenean armor, an explosive SpaceX engine test, the link between stomach paralysis and Ozempic, and more. Gizmodo Staff Published May 25, 2024
ScienceHealth What to Know About the Link Between Stomach Paralysis and Ozempic New research is the latest to link the use of Ozempic, Wegovy, and other GLP-1 drugs to a greater risk of gastroparesis. Here's what we know so far. By Ed Cara Published May 21, 2024 | Comments (0)
ScienceHealth Hims & Hers Will Sell Wegovy-Like Weight Loss Drugs for $199 The telehealth company's stock surged after the announcement Bruce Gil, Quartz Published May 20, 2024 | Comments (0)
Science Raw Milk Sales Soar as Misguided Notions of Bird Flu Immunity Spread Plus: The tech that got hit by the solar storm, orcas sink another yacht, and the truth behind Wegovy. Gizmodo Staff Published May 18, 2024
ScienceHealth Here’s What Happens to People Who Stay on Wegovy Long Term The results of the longest-running trial of semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, are here and looking positive. By Ed Cara Published May 14, 2024 | Comments (0)
ScienceHealth Experimental Weight Loss Procedure ‘Burns’ Stomach Lining to Curb Food Cravings In a new small trial of an experimental procedure, patients lost about 8% of their baseline weight and experienced a significant drop in their hunger. By Ed Cara Updated May 9, 2024 | Comments (0)
ScienceHealth Bernie Sanders Is Taking on Ozempic’s ‘Astronomically High’ Price Tag The Vermont senator is launching an investigation into why these game-changing diabetes and obesity drugs can cost more than $1,000 a month in America. By Ed Cara Published April 26, 2024 | Comments (0)
ScienceHealth Weight Loss Drug Users Are Giving Up Their Vices Ozempic and other weight loss drugs are coming for the alcohol and tobacco industries next Bruce Gil, Quartz Published April 23, 2024 | Comments (0)
Science NASA Spacecraft Sees a Lava Lake With Islands on Jupiter’s Moon Io Plus: Why Ozempic and other new weight-loss drugs aren't likely to be a repeat of the fen-phen crisis. Gizmodo Staff Published April 20, 2024
ScienceHealth The Newest Obesity Drug May Also Combat Sleep Apnea New data from Eli Lilly suggests that Zepbound can help people lose weight and have fewer episodes of obstructive sleep apnea at the same time. By Ed Cara Published April 17, 2024 | Comments (0)
ScienceHealth Fen-Phen Again? Why Ozempic and New Weight-Loss Drugs Are Different Some people fear that new obesity drugs will inevitably prove to be dangerous, but there are key distinctions from the fen-phen crisis of the 1990s. By Ed Cara Published April 15, 2024 | Comments (0)
ScienceHealth No Link Between Ozempic and Suicide Risk, Major EU Probe Finds It's the second recent investigation by health regulators to clear GLP-1 drugs of causing suicidal thoughts. By Ed Cara Published April 12, 2024 | Comments (0)
Tech NewsNews Medicare to Cover Wegovy for Patients With Serious Heart Risks Roughly 42% of Americans are obese, making the U.S. a huge market for anti-obesity drugs. By Matt Novak Published March 21, 2024 | Comments (0)
